Access cutting-edge post-ligation cardiac syndrome treatment through this clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.
Access post-ligation cardiac syndrome specialists in Atlanta at no cost
This study follows strict safety protocols and ethical guidelines
All study-related post-ligation cardiac syndrome treatment provided free
The goal of this Phase 3, randomized, masked clinical trial is to is to find out whether milrinone, when given to infants after PDA closure, will help the heart work better by supplying oxygen to the lungs and tissues. The main questions it aims to answer are: 1. to determine if milrinone decreases the risk of death or PLCS within 7 days of the procedure, compared to standard treatment; and 2. to determine the effects of milrinone on two-year survival and neurodevelopmental outcome.
Sponsor: NICHD Neonatal Research Network
Check if you qualify for this post-ligation cardiac syndrome clinical trial in Atlanta, GA
If you're searching for post-ligation cardiac syndrome treatment options in Atlanta, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced post-ligation cardiac syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.